Telesis Bio Statistics
Want to see TBIO full AI Analyst Report?
Telesis Bio (TBIO) Stock Statistics & Valuation Metrics
Total Valuation
Telesis Bio has a market cap or net worth of $862.49K. The enterprise value is $49.56M.
- Market Cap
- $862.49K
- Enterprise Value
- $49.56M
Share Statistics
Telesis Bio has 78,407,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 78,407,840
- Owned by Insiders
- ―
- Owned by Institutions
- 0.06%
Financial Efficiency
Telesis Bio’s return on equity (ROE) is -1.62 and return on invested capital (ROIC) is -72.66%.
- Return on Equity (ROE)
- -1.62
- Return on Assets (ROA)
- -0.68
- Return on Invested Capital (ROIC)
- -72.66%
- Return on Capital Employed (ROCE)
- -0.75
- Revenue Per Employee
- 705.36K
- Profits Per Employee
- -1.22M
- Employee Count
- 39
- Asset Turnover
- 0.39
- Inventory Turnover
- 2.62
Valuation Ratios
The current PE Ratio of Telesis Bio is -0.01. Telesis Bio’s PEG ratio is 0.00.
- PE Ratio
- -0.01
- PS Ratio
- 0.03
- PB Ratio
- 0.01
- Price to FCF
- -0.02
- Price to Operating Cash Flow
- -0.01
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Telesis Bio had revenue of 27.51M and earned -47.72M in profits. Earnings per share was -1.59.
- Revenue
- 27.51M
- Gross Profit
- 16.95M
- Operating Income
- -46.54M
- Pretax Income
- -47.70M
- Net Income
- -47.72M
- EBITDA
- -40.49M
- Earnings Per Share (EPS)
- -1.59
Cash Flow
In the last 12 months, operating cash flow was -22.85M and capital expenditures -890,000, giving a free cash flow of -23.74M billion.
- Operating Cash Flow
- -22.85M
- Free Cash Flow
- -23.74M
- Free Cash Flow per Share
- -1.22
Dividends & Yields
Telesis Bio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4673.90%
- Earnings Yield
- -15945.14%
Stock Price Statistics
- Beta
- 52.28
- 52-Week Price Change
- -8.33%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- 25.82
- Average Volume (3m)
- 608
Important Dates
Telesis Bio upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Aug 12, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Telesis Bio as a current ratio of 3.71, with Debt / Equity ratio of 116.39%
- Current Ratio
- 3.71
- Quick Ratio
- 3.22
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- -0.81
- Interest Coverage Ratio
- -14.99
Taxes
In the past 12 months, Telesis Bio has paid 24.00K in taxes.
- Income Tax
- 24.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Telesis Bio EV to EBITDA ratio is -0.83, with an EV/FCF ratio of -0.92.
- EV to Sales
- 1.22
- EV to EBITDA
- -0.83
- EV to Free Cash Flow
- -0.92
- EV to Operating Cash Flow
- -0.97
Balance Sheet
Telesis Bio has $4.51M in cash and marketable securities with $16.29M in debt, giving a net cash position of -$11.78M billion.
- Cash & Marketable Securities
- $4.51M
- Total Debt
- $16.29M
- Net Cash
- -$11.78M
- Net Cash Per Share
- -$0.15
- Tangible Book Value Per Share
- -$0.15
Margins
Gross margin is 61.62%, with operating margin of -169.18%, and net profit margin of -173.49%.
- Gross Margin
- 61.62%
- Operating Margin
- -169.18%
- Pretax Margin
- -173.40%
- Net Profit Margin
- -173.49%
- EBITDA Margin
- -147.20%
- EBIT Margin
- -162.11%
Scores
- Smart Score
- ―
- AI Score
- 36
